This report contains market size and forecasts of Pharma Sustained Release Excipient in global, including the following market information: Global Pharma Sustained Release Excipient Market Revenue, 2017-2022, 2023-2028, ($ millions) Global Pharma Sustained Release Excipient Market Sales, 2017-2022, 2023-2028, (Kiloton) Global top five Pharma Sustained Release Excipient companies in 2021 (%) The global Pharma Sustained Release Excipient market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. Gelatin Segment to Reach $ Million by 2028, with a % CAGR in next six years. The global key manufacturers of Pharma Sustained Release Excipient include Teva Pharmaceutical Industries, Mylan N.V., Valeant Pharmaceuticals International, Pfizer, Sun Pharmaceutical Industries, Novartis AG, AstraZeneca, GlaxoSmithKline and Allergan, etc. In 2021, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharma Sustained Release Excipient manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Pharma Sustained Release Excipient Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton) Global Pharma Sustained Release Excipient Market Segment Percentages, by Type, 2021 (%) Gelatin Polymers Minerals Sugars Chitosan Global Pharma Sustained Release Excipient Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton) Global Pharma Sustained Release Excipient Market Segment Percentages, by Application, 2021 (%) Pharmaceutical Health Care Others Global Pharma Sustained Release Excipient Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton) Global Pharma Sustained Release Excipient Market Segment Percentages, By Region and Country, 2021 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Pharma Sustained Release Excipient revenues in global market, 2017-2022 (Estimated), ($ millions) Key companies Pharma Sustained Release Excipient revenues share in global market, 2021 (%) Key companies Pharma Sustained Release Excipient sales in global market, 2017-2022 (Estimated), (Kiloton) Key companies Pharma Sustained Release Excipient sales share in global market, 2021 (%) Further, the report presents profiles of competitors in the market, key players include: Teva Pharmaceutical Industries Mylan N.V. Valeant Pharmaceuticals International Pfizer Sun Pharmaceutical Industries Novartis AG AstraZeneca GlaxoSmithKline Allergan Janssen Pharmaceuticals Mayne Pharma Group BASF International Flavors & Fragrances Ashland Global Evonik Industries Croda International Gattefosse Merck KGaA
1 Introduction to Research & Analysis Reports 1.1 Pharma Sustained Release Excipient Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Pharma Sustained Release Excipient Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 R
